EMERALD ADVISERS, LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 46 filers reported holding NEOS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$3,631,000
-33.1%
336,550
-11.2%
0.18%
-30.9%
Q4 2015$5,425,000
-19.6%
378,874
+17.9%
0.26%
-27.5%
Q3 2015$6,751,000321,3130.35%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,043,770$7,620,0002.51%
Stonepine Capital Management, LLC 565,100$4,125,0002.23%
DAFNA Capital Management LLC 209,873$1,532,0001.09%
Ghost Tree Capital, LLC 500,000$3,650,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,459,195$10,652,0000.57%
PURA VIDA INVESTMENTS, LLC 150,000$1,095,0000.44%
J. Goldman & Co LP 845,000$6,169,0000.33%
ESSEX INVESTMENT MANAGEMENT CO LLC 191,729$1,400,0000.20%
Opaleye Management Inc. 50,000$365,0000.15%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 50,000$365,0000.15%
View complete list of NEOS THERAPEUTICS INC shareholders